How to buy MDxHealth stock (MDxHealth SA)

MDxHealth is a diagnostics & research business based in the US. MDxHealth shares (MDXH) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $2.31 – an increase of 2.21% over the previous week. MDxHealth employs 300 staff and has a trailing 12-month revenue of around $84.7 million.

Our top picks for where to buy MDxHealth SA ADR stock

Buy MDxHealth stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

MDxHealth stock price (NASDAQ: MDXH)

Use our graph to track the performance of MDXH stocks over time.

MDxHealth shares at a glance

• Key figures

Information last updated 2024-12-26.

Latest market close	$2.31
52-week range	$1.55 - $4.64
50-day moving average more info button	$2.03
200-day moving average more info button	$2.49
Wall St. target price	$6.04
PE ratio more info button	N/A
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$-1.53

Is it a good time to buy MDxHealth stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

MDxHealth price performance over time

Historical closes compared with the close of $2.24 from 2024-12-26

1 week (2024-12-20)	-0.88%
1 month (2024-11-27)	14.29%
3 months (2024-09-27)	8.21%
6 months (2024-06-27)	-5.49%

1 year (2023-12-27)	-44.00%
2 years (2022-12-24)	N/A
3 years (2021-12-24)	N/A
5 years (2019-12-27)	11

MDxHealth financials

Revenue TTM	$84.7 million
Gross profit TTM	$19.2 million
Return on assets TTM	-11.02%
Return on equity TTM	-240.82%
Profit margin	-49.52%
Book value	$0.61
Market Capitalization more info button	$105.4 million

TTM: trailing 12 months

MDxHealth share dividends

We're not expecting MDxHealth to pay a dividend over the next 12 months.

You may also wish to consider:

Have MDxHealth's shares ever split?

MDxHealth's shares were split on a 1:10 basis on 13 November 2023 . So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your MDxHealth shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for MDxHealth shares which in turn could have impacted MDxHealth's share price.

MDxHealth share price volatility

Over the last 12 months, MDxHealth's shares have ranged in value from as little as $1.55 up to $4.64. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while MDxHealth's is -393982.88. This would suggest that MDxHealth's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, MDxHealth has bucked the trend.

To put MDxHealth's beta into context you can compare it against those of similar companies.

• Veracyte (VCYT.US): 1.668
• Personalis (PSNL.US): 1.945
• Sophia Genetics (SOPH.US): 1.032

MDxHealth overview

MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, Europe, and internationally. Its testing solutions includes Select mdx, a non-invasive urine test for prostate cancer that measures the expression of two mRNA cancer-related biomarkers; Confirm mdx for prostate cancer tissue test that validates epigenetic test that guides the detection of occult prostate cancer on a patient's previously biopsied negative tissue; and Resolved mdx for urinary tract infection that identifies personalized effective antibiotic options against the patient's infection. The company offers genomic prostate score which provides personalized genomic insights to both physicians and patients navigating the complexities of prostate cancer diagnosis and treatment. It sells its products through urology sales force, consisting of direct sales representatives, strategic account managers, and regional sales managers. The company was formerly known as OncoMethylome Sciences SA and changed its name to MDxHealth SA in October 2010. MDxHealth SA was incorporated in 2003 and is headquartered in Herstal, Belgium. .

Frequently asked questions

What percentage of MDxHealth is owned by insiders or institutions?
Currently 12.22% of MDxHealth shares are held by insiders and 48.656% by institutions. How many people work for MDxHealth?
Latest data suggests 300 work at MDxHealth. When does the fiscal year end for MDxHealth?
MDxHealth's fiscal year ends in December. Where is MDxHealth based?
MDxHealth's address is: CAP Business Center, Herstal, Belgium, 4040 What is MDxHealth's ISIN number?
MDxHealth's international securities identification number is: US58286E1029